DJ IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of IDEXX Laboratories Inc. $(IDXX)$ advanced 1.02% to $441.61 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.22% to 5,778.15 and Dow Jones Industrial Average falling 1.55% to 42,520.99.
This was the stock's second consecutive day of gains.
IDEXX Laboratories Inc. closed 23.19% below its 52-week high of $574.94, which the company achieved on March 8th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.11% to $165.42, Medtronic PLC $(MDT)$ fell 1.35% to $93.03, and Boston Scientific Corp. $(BSX)$ fell 1.20% to $103.61.
Trading volume (1.1 M) eclipsed its 50-day average volume of 676,295.
Data source: Dow Jones Market Data, FactSet. Data compiled March 4, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 04, 2025 16:54 ET (21:54 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.